CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 86 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,493 | -99.9% | 769,336 | -15.4% | 0.02% | -30.4% |
| Q3 2022 | $6,096,000 | +163.8% | 909,890 | +65.8% | 0.02% | +155.6% |
| Q2 2022 | $2,311,000 | +2039.8% | 548,843 | +1618.8% | 0.01% | – |
| Q1 2022 | $108,000 | -75.8% | 31,931 | -77.5% | 0.00% | -100.0% |
| Q4 2021 | $447,000 | -42.2% | 141,964 | -39.9% | 0.00% | -50.0% |
| Q3 2021 | $773,000 | +29.3% | 236,367 | +66.8% | 0.00% | 0.0% |
| Q2 2021 | $598,000 | -4.9% | 141,686 | +12.4% | 0.00% | -33.3% |
| Q1 2021 | $629,000 | -52.2% | 126,032 | +15.0% | 0.00% | -70.0% |
| Q2 2019 | $1,315,000 | – | 109,588 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |